注册 | 登录 | 充值

首页-> 学术资讯 -> 临床医学

[EuroPCR 2011]A New Leadership for EAPCI: interview with Dr Jean Fajadet, EAPCI President

临床医学

1970-01-01      

1806 0

  You will officially take over the presidency of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in September 2011 with the support of the newly elected Executive Board whose names were announced yesterday during the EAPCI General Assembly as a result of the elections for the positions of President-Elect, Secretary and Treasurer. What are your priorities for the Association?
  I will take over the presidency of EAPCI during the ESC congress to be held in Paris early September, 2011.
  I’ll have the immense pleasure and honour to work with a very experienced Board that has recently been elected for the next two years: Stephan Windecker as President-elect, Georges Sianos as Secretary and Marie-Claude Morice as Treasurer.
  Before outlining the priorities of the association during my presidency, I would like to personally thank William Wijns for his tremendous work since the creation of the association in 2006. He built the foundations and structure of this young and brilliant association. Carlo Di Mario also brought his personal touch to developing association activities.
  During my presidency, we will focus on 3 major objectives:
  The first is to increase the visibility and membership of EAPCI with the aim of becoming the largest and most dynamic association of the ESC family. This will only be possible with involvement and participation from the National Working Groups members. We will further develop networking and offer members of National Societies and Working Groups a way to take part in more activities.
  The second objective will be to strengthen the link between EAPCI, EuroPCR and ESC. I want to reinforce the relationship and communication between EAPCI and EuroPCR by stimulating the participation of EAPCI members in EuroPCR activities and in other meetings of the PCR family. I want to reinforce the link between EAPCI and ESC with, for instance, active participation of EAPCI in the interventional cardiology programme of the ESC congress. EAPCI is the natural link between EuroPCR and ESC. We must develop a close collaboration based on trust and a ‘win-win’ spirit to reach an optimal synergy between the three entities. EAPCI should be proud to be part of the ESC family and ESC should be proud to have EAPCI as one of its most active associations.
  The third objective is to continue to develop the different activities of the association in the field of Education and Information. We need the support of all cardiologists from the different National Working Groups. Their input is vital to bring our websites to life, to make EuroIntervention the best interventional cardiology journal and to develop different educational tools (textbooks, online learning tools, guidelines, seminars, meetings). We will work with Stephan to initiate a Clinical Trial Unit by establishing a platform for European clinical scientists in the field of interventional cardiology.
  Finally, I’ll work to further the development of the Stent for Life initiative. Again, I would like to thank William Wijns, Petr Widimsky, and Steen Dalby Kristensen for their involvement in the initiative as well as Zuzana for her continuous and excellent dedication to this project.
  Over the next two years, I’ll have the huge honour and responsibility of leading the association. My vision for the future of EAPCI is not just a two-year vision but more a four/five-year vision that I could share and implement with Stephan Windecker.


  选自《EuroPCR每日新闻》



科研资讯(站内): EAPCI候任主席 Jean Fajadet

百度浏览   来源 : 国际循环   


版权声明:本网站所有注明来源“医微客”的文字、图片和音视频资料,版权均属于医微客所有,非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源:”医微客”。本网所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,转载仅作观点分享,版权归原作者所有。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。 本站拥有对此声明的最终解释权。

科研搜索(百度):医学科研 EAPCI候任主席 Jean Fajadet





发表评论

注册或登后即可发表评论

登录注册

全部评论(0)

没有更多评论了哦~

科研资讯 更多>>
  • 肿瘤电场治疗Optune Lua获批治疗..
  • 成本更低的实体瘤抗癌新星:CAR-..
  • 文献速递-子宫内膜癌中的卵黄囊..
  • Nature|MSCs首次用于人体跟腱病..
  • 推荐阅读 更多>>
  • [EuroPCR 2011]直接PCI时使用比..
  • [EuroPCR 2011]动脉粥样硬化的MR..
  • [EuroPCR 2011]肥厚性梗阻性心肌..
  • [EuroPCR 2011]临床血管内光学相..
    • 相关阅读
    • 热门专题
    • 推荐期刊
    • 学院课程
    • 医药卫生
      期刊级别:国家级期刊
      发行周期:暂无数据
      出版地区:其他
      影响因子:暂无数据
    • 中华肿瘤
      期刊级别:北大核心期刊
      发行周期:月刊
      出版地区:北京
      影响因子:1.90
    • 中华医学
      期刊级别:CSCD核心期刊
      发行周期:周刊
      出版地区:北京
      影响因子:0.94